Texas Permanent School Fund’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-80,729
Closed -$4.37M 362
2024
Q2
$4.37M Sell
80,729
-5,087
-6% -$276K 0.04% 561
2024
Q1
$6.02M Buy
85,816
+1,111
+1% +$77.9K 0.05% 452
2023
Q4
$7.07M Buy
84,705
+4,262
+5% +$356K 0.06% 325
2023
Q3
$2.37M Sell
80,443
-1,716
-2% -$50.6K 0.02% 866
2023
Q2
$2.68M Sell
82,159
-3,843
-4% -$125K 0.02% 825
2023
Q1
$3.03M Buy
86,002
+21,246
+33% +$748K 0.03% 736
2022
Q4
$2.97M Sell
64,756
-2,953
-4% -$135K 0.05% 540
2022
Q3
$3.28M Buy
67,709
+5,802
+9% +$281K 0.05% 449
2022
Q2
$2.43M Buy
61,907
+2,438
+4% +$95.8K 0.04% 645
2022
Q1
$2.19M Sell
59,469
-1,008
-2% -$37.1K 0.03% 800
2021
Q4
$2.76M Sell
60,477
-1,300
-2% -$59.3K 0.03% 709
2021
Q3
$2.21M Buy
61,777
+8,316
+16% +$297K 0.03% 838
2021
Q2
$1.06M Buy
53,461
+334
+0.6% +$6.61K 0.01% 1208
2021
Q1
$1.24M Sell
53,127
-3,705
-7% -$86.2K 0.02% 1140
2020
Q4
$1.18M Sell
56,832
-9,030
-14% -$188K 0.01% 1099
2020
Q3
$1.43M Buy
65,862
+18,876
+40% +$409K 0.02% 961
2020
Q2
$1.11M Sell
46,986
-3,300
-7% -$77.7K 0.02% 989
2020
Q1
$593K Buy
50,286
+9,873
+24% +$116K 0.01% 1173
2019
Q4
$429K Buy
40,413
+474
+1% +$5.03K 0.01% 1363
2019
Q3
$455K Buy
39,939
+765
+2% +$8.72K 0.01% 1338
2019
Q2
$441K Buy
39,174
+2,026
+5% +$22.8K 0.01% 1343
2019
Q1
$301K Buy
37,148
+1,346
+4% +$10.9K ﹤0.01% 1430
2018
Q4
$226K Buy
35,802
+1,430
+4% +$9.03K ﹤0.01% 1456
2018
Q3
$339K Buy
34,372
+1,492
+5% +$14.7K ﹤0.01% 1428
2018
Q2
$273K Sell
32,880
-653
-2% -$5.42K ﹤0.01% 1472
2018
Q1
$241K Sell
33,533
-706
-2% -$5.07K ﹤0.01% 1472
2017
Q4
$279K Sell
34,239
-2,590
-7% -$21.1K ﹤0.01% 1456
2017
Q3
$534K Buy
36,829
+3,067
+9% +$44.5K 0.01% 1344
2017
Q2
$409K Buy
+33,762
New +$409K 0.01% 1388